Symp VId Use of Ultrasound in Preclinical Hemodynamic and Safety Assessment of Investigational Drugs

被引:0
|
作者
DeFelice, Albert [1 ]
机构
[1] US FDA, Off Drug Evaluat 1, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:122 / 122
页数:1
相关论文
共 38 条
  • [21] Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans
    Heal, David J.
    Gosden, Jane
    Smith, Sharon L.
    NEUROPHARMACOLOGY, 2018, 142 : 89 - 115
  • [23] Safety Assessment of the Use of Perflenapent Emulsion for Contrast Enhancement of Echocardiography and Diagnostic Radiology Ultrasound Studies
    Quay, Steven C.
    Eisenfeld, Amy J.
    CLINICAL CARDIOLOGY, 1997, 20 : 19 - 26
  • [24] Safety of Lipiodol use for assessment of tubal patency and therapeutic tubal flushing - Fluoroscopy versus ultrasound?
    Peart, Jane
    Sim, Robert
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2020, 64 (04) : 522 - 524
  • [25] Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies
    Quay, SC
    Eisenfeld, AJ
    CLINICAL CARDIOLOGY, 1997, 20 (10) : 19 - 26
  • [26] Safety and Efficacy of Pressure Wire Use in Hemodynamic Assessment of Paradoxical Low Flow Low Gradient Aortic Stenosis
    Fanari, Zaher
    Gunasekaran, Prasad
    Shaukat, Arslan
    Thapa, Jhapat
    Persad, Kamleish
    Hammami, Sumaya
    Weintraub, William
    Dawn, Buddhadeb
    Wiley, Mark
    Doorey, Andrew
    Tadros, Peter
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (03) : S65 - S65
  • [27] Utility and safety of pressure wires use in hemodynamic assessment of paradoxical low flow low gradient aortic stenosis
    Fanari, Z.
    Gunasekaran, P.
    Shaukat, A.
    Thapa, J.
    Persad, P.
    Hammamol, S.
    Dawn, B.
    Wiley, M.
    Weintraub, W.
    Doorey, A.
    Tadros, P.
    EUROPEAN HEART JOURNAL, 2017, 38 : 353 - 354
  • [28] Serious adverse drug reactions related to non-investigational drugs occurring in academic clinical trials: another source of safety information for risk assessment?
    Gimbert, A.
    Petitpain, N.
    Colin, A. L.
    Becker, M.
    Marty, V.
    Olivier-Abbal, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 5 - 6
  • [29] The influence of systemic cryotherapy on selected hemodynamic parameters and the assessment of the safety of its use in patients with successfully treated hypertension
    Wujek-Krajewska, Ewa
    Cudnoch-Jedrzejewska, Agnieszka
    Puchalska, Liana
    Chybowska, Barbara
    Janiszewski, Maciej
    Klimczak, Dominika
    Kuch, Marek
    CRYOBIOLOGY, 2017, 78 : 22 - 26
  • [30] Use of a rodent neurotoxicity screening battery in the preclinical safety assessment of recombinant-methionyl human brain-derived neurotrophic factor
    LeBel, CP
    Foss, JA
    NEUROTOXICOLOGY, 1996, 17 (3-4) : 851 - 863